Rapport Therapeutics (RAPP) to Release Quarterly Earnings on Thursday

Rapport Therapeutics (NASDAQ:RAPP) is expected to be announcing its earnings results before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.62) per share for the quarter.

Rapport Therapeutics Stock Down 11.0 %

Rapport Therapeutics stock opened at $11.78 on Wednesday. Rapport Therapeutics has a 52 week low of $11.43 and a 52 week high of $29.74. The stock has a 50-day moving average price of $15.86 and a 200 day moving average price of $19.76.

About Rapport Therapeutics

Rapport Therapeutics Inc is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc is based in BOSTON.